Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques

Kovacs, Kyle D, Ciulla, Thomas A, Kiss, Szilárd · 2022 · Expert Opinion on Biological Therapy

Abstract

INTRODUCTION: Ocular gene therapy represents fertile ground for rapid innovation, with ever-expanding therapeutic strategies, molecular targets, and indications. AREAS COVERED: Potential indications for ocular gene therapy have classically focused on inherited retinal disease (IRD) but more recently include acquired retinal diseases, such as neovascular age-related macular degeneration, geographic atrophy, and diabetic retinopathy. Ocular gene therapy strategies have proliferated recently, and include gene augmentation, gene inactivation, gene editing, RNA modulation, and gene-independent gene augmentation. Viral vector therapeutic constructs include adeno-associated virus and lentivirus and continue to evolve through directed evolution and rationale design. Ocular gene therapy administration techniques have expanded beyond pars plana vitrectomy with subretinal injection to intravitreal injection and suprachoroidal injection. EXPERT OPINION: The success of treatment for IRD, paired with the promise of clinical research in acquired retinal diseases and in administration techniques, has raised the possibility of in-office gene therapy for common retinal disorders within the next 5 to 10 years.

Overview

Integrity signals

Registry

Crossref · 10.1080/14712598.2022.2121646

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 88 references

Research works printed but not linked: 10

  1. Pennesi ME, 2022, Ophthalmol Retina, 2468
  2. Ho A, 2021, Presented at the Retina Society Meeting; September 20-October 2
  3. Ho AC, 2021, Presented at the Angiogenesis, Exudation, and Degeneration 2021 Conference
  4. Campochiaro PA, 2021, Presented at the Angiogenesis, Exudation, and Degeneration 2021 Conference
  5. Waheed N, 2022, Presented at: Angiogenesis, Exudation, and Degeneration
  6. Waheed N, Presented at the Angiogenesis, Exudation, and Degeneration 2021 Conference
  7. Li Q, 2008, Mol Vis, 14, 1760
  8. Pieramici D, 2021, Presented at: Annual Meeting of the American Society of Retina Specialists (ASRS)
  9. Emi K, 1989, Invest Ophthalmol Vis Sci, 30, 233
  10. London NJS, 2021, Presented at: Annual Meeting of the Retina Society. September 29-October 2

Cited by

See all 34

Metadata

Authors
Kovacs, K. D., Ciulla, T. A., & Kiss, S.
Affiliations
  • Weill Cornell Medicine (US)
  • Indiana University School of Medicine (US)
Corresponding author
Kiss, Szilárd
Venue
Expert Opinion on Biological Therapy
Published
2022-09-02
Volume
22
Issue
9
Pages
1193-1208
ISSN
  • 1471-2598 (ISSN-L)
  • 1744-7682
OpenAlex
W4294539283
Cited by
20
References
88
Citations by year
2026: 6 · 2025: 5 · 2024: 2 · 2023: 7
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Biological Therapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
ocular gene therapy, gene therapy vectors, adeno-associated virus, lentivirus, viral vector design, subretinal injection, intravitreal injection, suprachoroidal injection, inherited retinal disease, neovascular age-related macular degeneration, geographic atrophy, diabetic retinopathy, gene augmentation, gene inactivation, genome editing
MeSH terms
Dependovirus, Genetic Vectors, Humans, Retinal Diseases, Genetic Therapy, Gene Transfer Techniques, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques. https://app.cochat.ai/papers/10.1080/14712598.2022.2121646
The paper
Kovacs, K. D., Ciulla, T. A., & Kiss, S. (2022). Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2022.2121646

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.